Dericip Retard 300 (Etofylline (231mg) + Theophylline (69mg)

Dericip Retard 300 combines Etofylline (231 mg) and Theophylline (69 mg) in a sustained-release formulation designed to provide effective relief from respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Etofylline acts as a bronchodilator, relaxing the muscles in the airways to improve airflow, while Theophylline enhances lung function by dilating bronchial passages. This combination helps to alleviate symptoms such as wheezing, shortness of breath, and chest tightness, offering long-lasting control for patients with respiratory challenges.